116 related articles for article (PubMed ID: 32951717)
1. Clinical observation on the effect of Chinese medicine-"TCM formula" intervention on recurrence and metastasis of triple negative breast cancer.
Wang Y; Li JW; Qin YN; Sun CP; Chen JJ; Ruan YY; Chen LX; Liu S; Liu GY
Complement Ther Med; 2020 Aug; 52():102456. PubMed ID: 32951717
[TBL] [Abstract][Full Text] [Related]
2. The signaling pathways and targets of traditional Chinese medicine and natural medicine in triple-negative breast cancer.
Yang Z; Zhang Q; Yu L; Zhu J; Cao Y; Gao X
J Ethnopharmacol; 2021 Jan; 264():113249. PubMed ID: 32810619
[TBL] [Abstract][Full Text] [Related]
3. Clinical study on postoperative triple-negative breast cancer with Chinese medicine: Study protocol for an observational cohort trial.
Chen J; Qin Y; Sun C; Hao W; Zhang S; Wang Y; Chen J; Chen L; Ruan Y; Liu S
Medicine (Baltimore); 2018 Jun; 97(25):e11061. PubMed ID: 29923998
[TBL] [Abstract][Full Text] [Related]
4. The expression of androgen receptor in triple-negative breast cancer and the effect of a traditional Chinese medicine formula on disease-free survival.
Yu L; Yu Q; Xu C; Wang M; Song J; Gao X
Gland Surg; 2022 Nov; 11(11):1772-1783. PubMed ID: 36518802
[TBL] [Abstract][Full Text] [Related]
5. Chemotherapy in conjunction with traditional Chinese medicine for survival of patients with early female breast cancer: protocol for a non-randomized, single center prospective cohort study.
Liu CT; Chen YH; Huang YC; Chen SY; Tsai MY
Trials; 2019 Dec; 20(1):741. PubMed ID: 31847861
[TBL] [Abstract][Full Text] [Related]
6. Clinicopathological and prognostic characteristics of triple- negative breast cancer (TNBC) in Chinese patients: a retrospective study.
Li CY; Zhang S; Zhang XB; Wang P; Hou GF; Zhang J
Asian Pac J Cancer Prev; 2013; 14(6):3779-84. PubMed ID: 23886182
[TBL] [Abstract][Full Text] [Related]
7. [Survival benefit of an herbal formula for invigorating spleen for elderly patients with gastric cancer].
Zhao AG; Cao W; Xu Y; Zhao G; Liu BY; Cai Y; Yang JZ; Gu Y; Yuan W; Zhu YJ; Han YY; Yang JY
Zhong Xi Yi Jie He Xue Bao; 2010 Mar; 8(3):224-30. PubMed ID: 20226143
[TBL] [Abstract][Full Text] [Related]
8. [Survival of Patients with Metastatic Recurrent Triple-negative Breast Cancer].
Peng ZX; Zhong XR; Wang Z; Wang Y; Wang YP; Zheng H; Jing J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2016 Jul; 47(4):541-546. PubMed ID: 28591958
[TBL] [Abstract][Full Text] [Related]
9. Identification of patients with node-negative, triple-negative breast cancer who benefit from adjuvant cyclophosphamide, methotrexate, and 5-fluorouracil chemotherapy.
Wu CE; Chen SC; Lin YC; Lo YF; Hsueh S; Chang HK
Anticancer Res; 2014 Mar; 34(3):1301-6. PubMed ID: 24596377
[TBL] [Abstract][Full Text] [Related]
10. Outcome following local-regional recurrence in women with early-stage breast cancer: impact of biologic subtype.
Braunstein LZ; Niemierko A; Shenouda MN; Truong L; Sadek BT; Abi Raad R; Wong JS; Punglia RS; Taghian AG; Bellon JR
Breast J; 2015; 21(2):161-7. PubMed ID: 25559656
[TBL] [Abstract][Full Text] [Related]
11. Clinical and pathological factors influencing survival in a large cohort of triple-negative breast cancer patients.
Urru SAM; Gallus S; Bosetti C; Moi T; Medda R; Sollai E; Murgia A; Sanges F; Pira G; Manca A; Palmas D; Floris M; Asunis AM; Atzori F; Carru C; D'Incalci M; Ghiani M; Marras V; Onnis D; Santona MC; Sarobba G; Valle E; Canu L; Cossu S; Bulfone A; Rocca PC; De Miglio MR; Orrù S
BMC Cancer; 2018 Jan; 18(1):56. PubMed ID: 29310602
[TBL] [Abstract][Full Text] [Related]
12. Comparison of invasive micropapillary and triple negative invasive ductal carcinoma of the breast.
Chen HL; Ding A
Breast; 2015 Dec; 24(6):723-31. PubMed ID: 26392199
[TBL] [Abstract][Full Text] [Related]
13. Prospective comparison of outcome after treatment for triple-negative and non-triple-negative breast cancer.
Joyce DP; Murphy D; Lowery AJ; Curran C; Barry K; Malone C; McLaughlin R; Kerin MJ
Surgeon; 2017 Oct; 15(5):272-277. PubMed ID: 28277293
[TBL] [Abstract][Full Text] [Related]
14. Omitting radiation therapy in women with triple-negative breast cancer leads to worse breast cancer-specific survival.
Kindts I; Buelens P; Laenen A; Van Limbergen E; Janssen H; Wildiers H; Weltens C
Breast; 2017 Apr; 32():18-25. PubMed ID: 28012411
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of triple-negative versus non-triple-negative breast cancers managed with breast-conserving therapy.
Bhatti AB; Khan AI; Siddiqui N; Muzaffar N; Syed AA; Shah MA; Jamshed A
Asian Pac J Cancer Prev; 2014; 15(6):2577-81. PubMed ID: 24761867
[TBL] [Abstract][Full Text] [Related]
16. Cohort study on the effect of a combined treatment of traditional Chinese medicine and Western medicine on the relapse and metastasis of 222 patients with stage II and III colorectal cancer after radical operation.
YANG YF; GE JZ; WU Y; XU Y; LIANG BY; LUO L; WU XW; LIU DQ; ZHANG X; SONG FX; GENG ZY
Chin J Integr Med; 2008 Dec; 14(4):251-6. PubMed ID: 19082795
[TBL] [Abstract][Full Text] [Related]
17. [Effects of Modified Ruji Recipe in Preventing Relapse and Metastasis of Breast Cancer Patients with Negative Hormone Receptor].
Tian HQ; Wang YJ; Wang B; Pang DM; Jin J; Liang GW; Huang XQ; Chen XZ; Yang YL; Ren G
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2017 Feb; 37(2):169-173. PubMed ID: 30650268
[TBL] [Abstract][Full Text] [Related]
18. Treatment of triple-negative breast cancer with Chinese herbal medicine: A prospective cohort study protocol.
Meng H; Peng N; Yu M; Sun X; Ma Y; Yang G; Wang X
Medicine (Baltimore); 2017 Nov; 96(44):e8408. PubMed ID: 29095272
[TBL] [Abstract][Full Text] [Related]
19. The impact of molecular subtype on breast cancer recurrence in young women treated with contemporary adjuvant therapy.
Alabdulkareem H; Pinchinat T; Khan S; Landers A; Christos P; Simmons R; Moo TA
Breast J; 2018 Mar; 24(2):148-153. PubMed ID: 28707744
[TBL] [Abstract][Full Text] [Related]
20. Analysis of Risk of Recurrence by Subtype in ≤ 1-cm Breast Tumors.
Colonna SV; Higgins AK; Alvarez J; Saville BR; Lawrence J; Abramson VG
Clin Breast Cancer; 2016 Jun; 16(3):223-31. PubMed ID: 26683741
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
